BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9433485)

  • 21. Dysfunctional variants and the structural biology of the serpins.
    Carrell R; Lomas D; Stein P; Whisstock J
    Adv Exp Med Biol; 1997; 425():207-22. PubMed ID: 9433503
    [No Abstract]   [Full Text] [Related]  

  • 22. The complex between mesentericopeptidase and eglin-C.
    Dauter Z; Betzel C; Genov N; Wilson KS
    Adv Exp Med Biol; 1996; 379():1-4. PubMed ID: 8796304
    [No Abstract]   [Full Text] [Related]  

  • 23. The structural puzzle of how serpin serine proteinase inhibitors work.
    Wright HT
    Bioessays; 1996 Jun; 18(6):453-64. PubMed ID: 8787534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serpins: finely balanced conformational traps.
    Pike RN; Bottomley SP; Irving JA; Bird PI; Whisstock JC
    IUBMB Life; 2002 Jul; 54(1):1-7. PubMed ID: 12387568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced structure of a helical switch as a mechanism to regulate enzymatic activity.
    Nomura AM; Marnett AB; Shimba N; Dötsch V; Craik CS
    Nat Struct Mol Biol; 2005 Nov; 12(11):1019-20. PubMed ID: 16244665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
    Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common protein architecture and binding sites in proteases utilizing a Ser/Lys dyad mechanism.
    Paetzel M; Strynadka NC
    Protein Sci; 1999 Nov; 8(11):2533-6. PubMed ID: 10595561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Picture story. The 'serpin'ator.
    Konforti B
    Nat Struct Biol; 2000 Nov; 7(11):1005. PubMed ID: 11062552
    [No Abstract]   [Full Text] [Related]  

  • 29. Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition.
    Simonovic M; Gettins PGW ; Volz K
    Protein Sci; 2000 Aug; 9(8):1423-7. PubMed ID: 10975564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing oriented protein structural sites using biochemical properties.
    Bagley SC; Wei L; Cheng C; Altman RB
    Proc Int Conf Intell Syst Mol Biol; 1995; 3():12-20. PubMed ID: 7584427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amplified mouse squamous cell carcinoma antigen gene locus contains a serpin (Serpinb3b) that inhibits both papain-like cysteine and trypsin-like serine proteinases.
    Askew DJ; Askew YS; Kato Y; Luke CJ; Pak SC; Brömme D; Silverman GA
    Genomics; 2004 Jul; 84(1):166-75. PubMed ID: 15203214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the Achilles' heel of hepatitis C virus.
    Lemon SM
    Hepatology; 1997 Apr; 25(4):1035-7. PubMed ID: 9096617
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serpin structures.
    Engh RA; Schulze AJ; Huber R; Bode W
    Behring Inst Mitt; 1993 Dec; (93):41-62. PubMed ID: 8172585
    [No Abstract]   [Full Text] [Related]  

  • 35. Serine protease mechanism and specificity.
    Hedstrom L
    Chem Rev; 2002 Dec; 102(12):4501-24. PubMed ID: 12475199
    [No Abstract]   [Full Text] [Related]  

  • 36. Proteinase-protein inhibitor interaction.
    Bode W; Huber R
    Biomed Biochim Acta; 1991; 50(4-6):437-46. PubMed ID: 1801707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiological relations and clinical significance of serine protease inhibitors (serpins)].
    Misz M; Fülep E
    Orv Hetil; 1990 Aug; 131(34):1851-2, 1855-9. PubMed ID: 2204865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.
    Weiss A; Joerss H; Brockmeyer J
    PLoS One; 2014; 9(10):e111363. PubMed ID: 25347319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shape-shifting serpins.
    Riddihough G
    Nature; 1994 Apr; 368(6471):570. PubMed ID: 8139695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of granzymes by serpins.
    Kaiserman D; Bird PI
    Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.